Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries

Autor: Stine Gry Kristensen, Ajay Kumar, Linn Salto Mamsen, Bhanu Kalra, Susanne Elisabeth Pors, Jane Alrø Bøtkjær, Kirsten Tryde Macklon, Jens Fedder, Erik Ernst, Kate Hardy, Stephen Franks, Claus Yding Andersen
Přispěvatelé: Genesis Research Trust
Rok vydání: 2022
Předmět:
EXPRESSION
Anti-Mullerian Hormone
BETA SUPERFAMILY
Endocrinology
Diabetes and Metabolism

Inhibins/metabolism
Clinical Biochemistry
MUTATION ANALYSIS
Growth Differentiation Factor 9
follicle fluid
Biomarkers/analysis
Biochemistry
Endocrinology & Metabolism
Endocrinology
BMP15
Transforming Growth Factor beta
PCOS
Humans
Inhibins
Science & Technology
Anti-Mullerian Hormone/analysis
Polycystic Ovary Syndrome/diagnosis
INHIBIN-B
GROWTH-DIFFERENTIATION FACTOR-9
Oocytes/metabolism
Biochemistry (medical)
MORPHOGENETIC PROTEIN 15
Follicular Fluid/chemistry
WOMEN
1103 Clinical Sciences
GDF9
GRANULOSA-CELLS
CUMULUS CELLS
Follicular Fluid
cumulin
Oocytes
1114 Paediatrics and Reproductive Medicine
Female
Bone Morphogenetic Protein 15/analysis
antral follicle
MESSENGER-RNA
Bone Morphogenetic Protein 15
Life Sciences & Biomedicine
Transforming Growth Factor beta/metabolism
Biomarkers
Growth Differentiation Factor 9/analysis
Polycystic Ovary Syndrome
Zdroj: E3383
E3374
Kristensen, S G, Kumar, A, Mamsen, L S, Kalra, B, Pors, S E, Bøtkjær, J A, Macklon, K T, Fedder, J, Ernst, E, Hardy, K, Franks, S & Andersen, C Y 2022, ' Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries ', The Journal of Clinical Endocrinology & Metabolism, vol. 107, no. 8, pp. e3374-e3383 . https://doi.org/10.1210/clinem/dgac272
Kristensen, S G, Kumar, A, Mamsen, L S, Kalra, B, Pors, S E, Bøtkjær, J A, Macklon, K T, Fedder, J, Ernst, E, Hardy, K, Franks, S & Andersen, C Y 2022, ' Intrafollicular Concentrations of the Oocytesecreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries ', Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 8, pp. E3374-E3383 . https://doi.org/10.1210/clinem/dgac272
ISSN: 1945-7197
0021-972X
DOI: 10.1210/clinem/dgac272
Popis: Context The oocyte-secreted factors growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) play essential roles in follicle development and oocyte maturation, and aberrant regulation might contribute to the pathogenesis of polycystic ovary syndrome. Objective Are there measurable differences in concentrations of GDF9, BMP15, and the GDF9/BMP15 heterodimer in small antral follicle fluids from women with and without polycystic ovaries (PCO)? Design and Setting Follicle fluids (n = 356) were collected from 4- to 11-mm follicles in unstimulated ovaries of 87 women undergoing ovarian tissue cryopreservation for fertility preservation. Patients Twenty-seven women with PCO were identified and 60 women without PCO-like characteristics (non-PCO women) were matched according to age and follicle size. Main outcome measures Intrafollicular concentrations of GDF9, BMP15, GDF9/BMP15 heterodimer, anti-Mullerian hormone (AMH), inhibin-A and -B, total inhibin, activin-B and -AB, and follistatin were measured using enzyme-linked immunosorbent assays. Results The detectability of GDF9, BMP15, and the GDF9/BMP15 heterodimer were 100%, 94.4%, and 91.5%, respectively, and concentrations were significantly negatively correlated with increasing follicle size (P Conclusions Intrafollicular concentrations of GDF9 and BMP15 varied inversely in women with PCO reflecting an aberrant endocrine environment. An increased GDF9:BMP15 ratio may be a new biomarker for PCO.
Databáze: OpenAIRE